A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma.

Geynisman, Daniel M; Zha, Yuanyuan; Kunnavakkam, Rangesh; Aklilu, Mebea; Catenacci, Daniel Vt; Polite, Blase N; Rosenbaum, Cara; Namakydoust, Azadeh; Karrison, Theodore; Gajewski, Thomas F; Kindler, Hedy L

Geynisman, Daniel M; Zha, Yuanyuan; Kunnavakkam, Rangesh; Aklilu, Mebea; Catenacci, Daniel Vt; Polite, Blase N; Rosenbaum, Cara; Namakydoust, Azadeh; Karrison, Theodore; Gajewski, Thomas F; Kindler, Hedy L.

Afiliación

Geynisman DM; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
Zha Y; University of Chicago Cancer Research Center, Chicago, IL, USA.
Kunnavakkam R; University of Chicago Cancer Research Center, Chicago, IL, USA.
Aklilu M; Department of Health Studies, University of Chicago, Chicago, IL, USA.
Catenacci DV; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
Polite BN; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
Rosenbaum C; University of Chicago Cancer Research Center, Chicago, IL, USA.
Namakydoust A; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
Karrison T; University of Chicago Cancer Research Center, Chicago, IL, USA.
Gajewski TF; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
Kindler HL; University of Chicago Cancer Research Center, Chicago, IL, USA.

J Immunother Cancer ; 1: 8, 2013.

Article en En | MEDLINE | ID: mdl-24829746

Palabras clave

CEA; Immunization; Pancreatic Cancer; Vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Immunother Cancer Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google